オハイオにおける若年性関節炎の臨床試験
オハイオ内の拠点で、若年性関節炎に関する8件の研究が参加者を募集しています。
オハイオ内の都市
公式研究テキスト（英語）
Allogeneic Hematopoietic Cell Transplantation for Refractory Systemic Juvenile Idiopathic Arthritis.
- Cincinnati Children's Hospital Medical Center, Cincinnati
被験者募集中観察研究
35歳以下 · 全性別 · 2026/09/29更新 · NCT07845942Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
- Cincinnati Childrens Hospital, Cincinnati
- Univ Hosp Cleveland Medical Center, Cleveland
被験者募集中第1相
2歳〜17歳 · 全性別 · 2026/09/28更新 · NCT06751238Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
- Nationwide Children's Hospital, Columbus
被験者募集中第3相
2歳〜21歳 · 全性別 · 2026/09/25更新 · NCT06654882A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cincinnati Children's Hospital Medical Center, Cincinnati
被験者募集中第3相
3歳以上 · 全性別 · 2026/09/25更新 · NCT06663332Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
- Cincinnati Childrens Hospital Medical Center /ID# 251827, Cincinnati
被験者募集中第3相
1歳〜17歳 · 全性別 · 2026/09/15更新 · NCT05609630A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- MetroHealth Medical Center /ID# 262377, Cleveland
- Cleveland Clinic - Cleveland /ID# 276655, Cleveland
被験者募集中第3相
5歳〜17歳 · 全性別 · 2026/09/01更新 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Metrohealth Medical Center, Cleveland
- 他2件
被験者募集中観察研究
21歳以下 · 全性別 · 2026/08/27更新 · NCT02418442The BRIDGE Pain Study
- Cincinnati Children's Hospital, Cincinnati
被験者募集中観察研究
14歳〜26歳 · 全性別 · 2026/05/22更新 · NCT07602595ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。